| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lyra Therapeutics, Inc. | SVP of Commercial Strategy and Market Development | Common Stock | 36,667 | $108,674 | $2.96 | 31 Jan 2023 | Direct |
| Lyra Therapeutics, Inc. | SVP of Commercial Strategy and Market Development | Stock Option | 55,000 | 31 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LYRA | Lyra Therapeutics, Inc. | 31 Jan 2023 | 2 | $0 | 4 | SVP of Commercial Strategy and Market Development | 02 Feb 2023, 16:12 |
| LYRA | Lyra Therapeutics, Inc. | 12 Feb 2022 | 1 | $0 | 4 | SVP of Commercial Strategy and Market Development Exhibit 24 - Power of Attorney | 15 Feb 2022, 20:31 |